Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms
Year: 2021
Type: article
Source: Cancer Immunology Immunotherapy
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Merck, National Cancer Institute
Awards: G156276794, G5862918134, G921727105
OpenAlex ID: W3120733576
